- Filed
- Dec 11, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Dec 5, 2024 | 5.71M sh |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $170.01K |
| Current Liabilities | Q2 2025 · Apr 30, 2024 | $174.57K |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $317.86K |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $299.43K |
| Current Assets | Q2 2025 · Oct 31, 2024 | $0 |
| Current Assets | Q2 2025 · Apr 30, 2024 | $0 |
| Total Assets | Q2 2025 · Oct 31, 2024 | $37.77K |
| Total Assets | Q2 2025 · Apr 30, 2024 | $38.75K |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $8.04K |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $15.08K |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $7.75K |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $15.89K |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 5.48M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 4.36M sh |
| Operating Cash Flow | Q2 2025 · Oct 31, 2023 | −$27.94K |
| Stockholders Equity restated | Q2 2025 · Oct 31, 2023 | $233.06K |
| Stockholders Equity restated | Q2 2025 · Jul 31, 2023 | $398.58K |
| Stockholders Equity restated | Q2 2025 · Apr 30, 2023 | $388.32K |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | $0.00 |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | −$0.46 |
| Net Income | Q2 2025 · Oct 31, 2023 | −$9.48K |
| Net Income | Q2 2025 · Oct 31, 2023 | −$2.02M |
| Operating Income | Q2 2025 · Oct 31, 2023 | −$7.75K |
| Operating Income | Q2 2025 · Oct 31, 2023 | −$2.02M |